Relationship of depressive and eating disorders, quality of life in women with complicated type 2 diabetes mellitus

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Underestimation of depressive and eating disorders in patients with type 2 diabetes mellitus (T2 DM) can affect the compensation of carbohydrate metabolism, the occurrence of complications, and affect the patient’s subjective sense of health.

The aim: to analyze the relationship between eating disorders, depressive disorders, and quality of life in women with complicated T2 DM.

Material and methods. 382 women with T2 DM and microvascular complications were studied. The control group consisted of patients without diabetes (n=121). A clinical examination of the selected contingent was carried out. The work used DEBQ and MOS SF-36 questionnaires and V. Tsung’s technique.

Results. At the time of the study, 21,9% of patients with T2 DM suffered from depression. The rate of depressive disorders in patients with diabetes was significantly higher than in the control group. Depressive disorders in women with T2 DM increased with age (r=+0,9, p=0,0001). A relationship was found between the degree of depressive disorders and BMI (r=+0.5; p=0.02), waist circumference (r=+0,89; p=0,0001). The presence of a negative correlation of depressive disorders with indicators of carbohydrate metabolism and external type of eating behavior has been established. Disorders in the emotional sphere significantly reduced the scores of the main characteristics of quality of life.

Conclusion. Depressive disorders in women with T2 DM were registered more often than in the control group and correlated with age, metabolic disorders, and subjective feelings of health. The results obtained significantly actualize the problem of controllability of depressive disorders and eating behavior in patients with T2 DM, the solution of which is impossible without an interdisciplinary approach.

Full Text

Restricted Access

About the authors

Tatyana P. Demicheva

Academician E.A. Wagner Perm State Medical University of the Ministry of Healthcare of Russia

Author for correspondence.
Email: demich-perm@mail.ru
ORCID iD: 0000-0002-5422-8700
SPIN-code: 3743-3914

PhD in Medical Sciences, Associate Professor of the Department of Endocrinology and Clinical Pharmacology

Russian Federation, Perm

References

  1. Buhren K., Schwarte R., Fluck F. Comorbid psychiatric disorders in female adolescents with first-onset anorexia nervosa. Eur Eat Disord Rev. 2014; 22(1): 39–44. http://dx.doi.org/10.1002/erv.2254.
  2. Practice guideline for the treatment of patients with eating disorders (revision). Am J Psychiatry. 2000; 157(1 Suppl): 1–39.
  3. Мазо Г.Э., Рукавишников Г.В, Кибитов А.О. с соавт. Нарушения пищевого поведения у пациентов с депрессивным расстройством: патофизиологические механизмы коморбидности. Успехи физиологических наук. 2019; 50(2): 31–41. [Mazo G.E., Rukavishnikov G.V., Kibitov A.O. et al. Eating disorders in patients with depressive disorder: Pathophysiological mechanisms of comorbidity. Uspekhi fiziologicheskikh nauk = Advances in the Physiological Sciences. 2019; 50(2): 31–41 (In Russ.)]. http://dx.doi.org/10.1134/S0301179819020073. EDN: WLUXQB.
  4. Katon W., Russo J., Lin E.H.B. Diabetes and poor disease control: Is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med. 2009; 71(9): 965–72. http://dx.doi.org/10.1097/PSY.0b013e3181bd8f55.
  5. Вербовой А.Ф., Шаронова Л.А. Анализ нарушений пищевого поведения, депрессивных и тревожных расстройств у женщин с сахарным диабетом. Эндокринология. Новости. Мнения. Обучение. 2018; 7(2): 60–66. [Verbovoi A.F., Sharonova L.A. Analysis of eating disorders, depressive and anxiety disorders in women with diabetes mellitus. Endokrinologiya. Novosti. Mneniya. Obucheniye = Endocrinology. News. Opinions. Education. 2018; 7(2): 60–66 (In Russ.)]. http://dx.doi.org/10.24411/2304-9529-2018-12006. EDN: XXSEJV.
  6. Van Strien, T., Frijters, J.E.R., Bergers, G.P.A., Defares, P.B. The Dutch Eating Behavior Questionnaire (DEBQ) for assessment of restrained, emotional, and external eating behavior. Int J Eat Disord. 1986; 5: 295–315. http://dx.doi.org/10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T.
  7. Zung W.W.K. The depression status inventory: An adjunct to the self-rating depression scale. J Clin Psychol. 1972; 28(4): 539–43. https://dx.doi.org/10.1002/1097-4679(197210)28:4<539::aid-jclp2270280427>3.0.co;2-s.
  8. Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине. М.: Олма-Медиа-групп. 2007; 320 с. [Novikov A.A., Ionova T.I. Guidelines for the study of quality of life in medicine. Moscow: Olma-Media-group. 2007; 320 pp. (In Russ.)]. ISBN: 978-5-373-01011-5.
  9. Решетников В.А. Основы статистического анализа в медицине. Учебное пособие. М.: Медицинская информатика и статистика, телемедицина. 2020; 176 с. [Reshetnikov V.A. Fundamentals of statistical analysis in medicine. A tutorial. Moscow: Medical Informatics and Statistics, Telemedicine. 2020; 176 pp. (In Russ)]. ISBN: 978-5-9986-0382-2.
  10. Бобров А.Е., Старостина Е.Г., Агамамедова И.Н. с соавт. Психические расстройства при сахарном диабете 2-го типа. Журнал неврологии и психиатрии им. С.С. Корсакова. 2021; 121(7): 22–30. [Bobrov A.E., Starostina E.G., Agamamedova I.N. et al. Mental disorders in type 2 diabetes. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2021; 121(7): 22–30 (In Russ.)]. https://dx.doi.org/10.17116/jnevro202112107122. EDN: TXIPKK.
  11. Tzeng W.C. Gender differences in metabolic syndrome risk factors among patients with serious mental illness. Int J Ment Health Nurs. 2020; 29(2): 254–65. https://dx.doi.org/10.1111/inm.12670.
  12. Biggers A. Relationship between depression, sleep quality, and hypoglycemia among persons with type 2 diabetes. J Clin Transl Endocrinol. 2019: 15: 62–64. https://dx.doi.org/10.1016/j.jcte.2018.12.007.
  13. Reis D. J., Ilardi S.S., Namekata M.S. et al. The depressogenic potential of added dietary sugars. Med Hypotheses. 2020; 134: 109421. https://dx.doi.org/10.1016/j.mehy.2019.109421.
  14. Fisher L., Glasgow R.E., Strycker L.A. The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diabetes Care. 2010; 33(5): 1034–103. https://dx.doi.org/10.2337/dc09-2175.
  15. Ismail K., Winkley K, Stahl D. A cohort study of people with diabetes and their first foot ulcer: The role of depression on mortality. Diabetes Care. 2007; 30(6): 1473–79. https://dx.doi.org/10.2337/dc06-2313.
  16. Honkasalo M.T., Elonheimo О.М., Sane Т. Severe hypoglycemia in drug-treated diabetic patients needs attention: A population-based study. Scand J Prim Health Care. 2011; 29(3): 165–70. https://dx.doi.org/10.3109/02813432.2011.580090.
  17. Katon W.J., Young B., Russo J. Association of depression with increased risk of severe hypoglycemic episodes in patients with diabetes. Ann Fam Med. 2013; 11(3): 245–50. https://dx.doi.org/10.1370/afm.1501.
  18. Mohseni S. Neurologic damage in hypoglycemia. Handb Clin Neurol. 2014; 126: 513–32. https://dx.doi.org/10.1016/B978-0-444-53480-4.00036-9.
  19. Smith L., Chakraborty D., Smith L., Bhattacharya P. Exposure to hypoglycemia and risk of stroke. Ann NY Acad Sci. 2018; 1431(1): 25–34. https://dx.doi.org/10.1111/nyas.13872.
  20. Farooq R.K. Role of inflammatory cytokines in depression: Focus on interleukin-1β. Biomed Rep. 2017; 6(1): 15–20. https://dx.doi.org/10.3892/br.2016.807.
  21. Mansur R.B., Fries G.R., Subramaniapillai M. Expression of dopamine signaling genes in the post-ortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes. J Psychiatr Res. 2018; 107: 128–35. https://dx.doi.org/10.1016/j.jpsychires.2018.10.020.
  22. Nash A.I. Crosstalk between insulin and dopamine signaling: A basis for the metabolic effects of antipsychotic drugs. J Chem Neuroanat. 2017: 83–84: 59–68. https://dx.doi.org/10.1016/j.jchemneu.2016.07.010.
  23. Мищенкова Т.В., Звенигородская Л.А., Варванина Г.Г. с соавт. Роль гормонов и типов пищевого поведения в развитии метаболического синдрома. Экспериментальная и клиническая гастроэнтерология. 2010; (7): 12–19. [Mishchenkova T.V., Zvenigorodskaya L.A., Varvanina G.G. et al. The role of hormones and types of eating behavior in the development of metabolic syndrome. Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2010; (7): 12–19 (In Russ.)]. EDN: MVAJRZ.
  24. Гречка П.С., Белобородова А.В., Гуменюк Л.Н. Взаимосвязь депрессии и сахарного диабета 2 типа. Международный научно-исследовательский журнал. 2020; (7–2): 75–80. [Grechka P.S., Beloborodova A.V., Gumenyuk L.N. The relationship between depression and type 2 diabetes. Mezhdunarodnyy nauchno-issledovatel’skiy zhurnal = International Research Journal. 2020; (7–2): 75–80 (In Russ.)]. https://dx.doi.org/10.23670/IRJ.2020.97.7.048. EDN: ZFSJVB.
  25. Сорокина Ю.А., Занозин А.В., Занозина О.В. Сонливость, депрессия и ожирение у пациентов с сахарным диабетом 2-го типа разного пола как мишень для фармакологической коррекции. Медицинский совет. 2020; (7): 79–83. [Sorokina Yu.A., Zanozin A.V., Zanozina O.V. Drowsiness, depression and obesity in patients with type 2 diabetes mellitus of different sex as a target for pharmacological correction. Meditsinskiy sovet = Medical Council. 2020; (7): 79–83 (In Russ.)]. https://dx.doi.org/10.21518/2079-701X-2020-7-80-84. EDN: ODEMHX.
  26. Старостина Е.Г., Володина М.Н., Старостин И.В., Бобров А.Е. Депрессия и сахарный диабет как коморбидные заболевания. РМЖ. 2017; 25(22): 1613–1620. [Starostina E.G., Volodina M.N., Starostin I.V., Bobrov A.E. Depression and diabetes mellitus as comorbid diseases. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2017; 25(22): 1613–1620 (In Russ.)]. EDN: YLAYET.
  27. Kan C. Genetic overlap between type 2 diabetes and depression in a Sri Lankan population twin sample. Psychosom Med. 2020; 82(2): 247. https://dx.doi.org/10.1097/PSY.0000000000000771.
  28. Victoria G.M., Dampil O.A. Prevalence of depression among patients with type 2 diabetes mellitus and its associated clinical factors. J ASEAN Fed Endocr Soc. 2019; 34(2): 197–203. https://dx.doi.org/10.15605/jafes.034.02.11.
  29. Egede L.E. Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care. 2004; 27(7): 1751–53. https://dx.doi.org/10.2337/diacare.27.7.1751.
  30. Rustad J.K., Musselman D.L., Nemeroff C.B. The relationship of depression and diabetes: Pathophysiological and treatment implications. Psychoneuroendocrinology. 2011; 36(9): 1276–86. https://dx.doi.org/10.1016/j.psyneuen.2011.03.005.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies